Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

Clinical trial NCT03206203 · COMPLETED

Trial details

NCT number: NCT03206203
Sponsor: Vanderbilt-Ingram Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Stage IV Breast Cancer HER2 Negative Invasive Breast Cancer

Start date: 2017-08-29
Primary completion: 2022-11-30
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.